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Objective: Recently a publication of Brenner et al. introduced 11 genetically distinct species within the genus 
Citrobacter. These newly recognized Citrobacterspecies can be classified by means of their biochemical characteristics. 
The aim of this study was to examine the distribution and susceptibility of Citrobacterisolates in our patient population. 
Methods: A total of 126 samples--containing a Citrobacterspecies-was collected from 116 hospitalized patients during 
a 6-month period. Organisms were identified according to standard procedures. Antimicrobial susceptibility testing was 
performed by agar dilution on Mueller-Hinton agar, and interpretation was based on NCCLS criteria. 
Results: C. freundiiwas the most common organism isolated (n=59),  followed by C. braakii(n=25) and C. &oseri(n=23). 
The urinary tract and the respiratory tract were found to be the predominant sites of colonization or infection, accounting 
for 45% and 32% of all isolates respectively. It appeared that young children (<I2 months old) and the elderly were most 
at risk of acquiring Citrobacter. Two-thirds of all specimens contained other organisms in addition to Citrobacter. Most 
Citrobacter isolates were related with a predisposing factor. Species-related differences were found in the susceptibility 
pattern. 
Conclusions: These findings suggest that citrobacteria are important opportunistic pathogens contributing to coloniza- 
tion or infection in our hospital population. 
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The genus Citrobacter consists of Gram-negative, 
facultative anaerobic, motile bacilli with growth on 
Simmons citrate medmm (hence its name). These 
bacilli are commonly found in water, soil, food and 
the intestinal tracts of animals and humans. A new 
publication of Brenner et al. [l] proposed the intro- 
duction of 11 genetically distinct species within the 
genus Citrobacter. The 11 species are: C. koseri (formerly 
described as C. diversus), C. amalonaticus, C. farmeri, C. 
jeundii, C. youngae, C. braakii, C. werkmanii, C. sedlakii 
and the three unnamed groups (Citrobacter species 9, 10 
and 11). The term ‘C. jeundii complex’ covers the last 
eight Citrobacter species mentioned. Citrobacteria have 
been associated with a variety of infectious diseases. 
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Amongst others, hospital-acquired bacteremias, endo- 
carditis, urinary tract infections, neonatal meningitis 
and brain abscess have been reported [2-91. The etio- 
logic significance of citrobacteria in diarrheal illnesses 
has been put forward in some studies, but is still unclear 
[lO,ll]. We conducted this study to evaluate some 
aspects of Citrobacter isolates of patients staying at our 
university hospital. 
MATERIALS AND METHODS 
Bacterial strains and patients 
A total of 126 samples was collected during a 6-month 
period (from 1 November 1994 to 30 April 1995) fkom 
clinical specimens submitted to the microbiology 
laboratory of the University Hospital of Leuven. This 
study involved 116 patients &om whom a Citrobacter 
species was isolated. In eight patients citrobacteria were 
obtained from two or more f ierent  isolation sites. The 
informa-tion obtained from the medical records of the 
patients included the patient’s age, sex, additional 
underlying diseases and possible risk factors. 
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Biochemical tests 
A preliminary subdlvision of the Citrobacter isolates into 
C. koseri, members of the C. amalonaticus group (this 
group consists of C. amalonaticus and C. farmeri, pre- 
viously described as C. amalonaticus biogroup 1) or 
members of the C. jeundii complex was performed 
with the following tests: H2S and indole production, 
malonate utilization, and acid production fiom adonitol 
and D-arabitol[12]. Further biochemical idendication 
of the Citrobucter strains to the species level was 
performed according to standard procedures based on 
the criteria of Brenner et al. [l]. Sugar fermentation 
was performed in Phenol Red Broth. Tests were read 
daily, and final results were recorded after 7 days of 
incubation. All media were incubated at 36 k 1 "C. 
Antimicrobial susceptibility testing 
The antimicrobial susceptibility was determined by 
agar dilution on Mueller-Hinton agar. For each anti- 
biotic one or two fixed concentrations, as indicated, 
were used. From each strain approximately lo4 CFU/ 
spot was inoculated with the multipoint inoculator. 
After overnight incubation at 36 k 1 "C the Mueller- 
Hinton plates were examined. Susceptibility patterns 
were determined by means of inhibition of visible 
growth of the organism after incubation. All strains 
were tested for their sensitivity accordmg to the NCCLS 
breakpoints (amoxiclavulanate, piperacillin/tazobactam 
and co-trimoxazole are combinations of two anti- 
biotics. The concentrations of both antibiotics are 
given): ampicillin (8 mg/L), amoxiclavulanate (8 mg/L), 
piperacillin (16 mg/L), piperacillin/tazobactam (1612 
mg/L), cefazolin (8 mg/L), cefuroxime (8 mg/L), 
cefotaxime (8 mg/L), cefkidime (8 mg/L), cefepime 
(8 mg/L), imipenem (4 mg/L), co-trimoxazole (2138 
mg/L), gentamicin (4 mg/L), tobramycin (4 mg/L), 
amikacin (16 mg/L), nitrofurantoin (32 mg/L), and 
ofloxacin (2 mg/L). For temocillin 16 mg/L was taken 
as the breakpoint. 
RESULTS 
Identification and frequency distribution 
of Cihoibacfer species 
During the 6 months of study, 126 Citrobacter isolates 
were observed in specimens of 116 hospitalized 
patients. From six patients and two patients we isolated 
the same Citrobacter species fi-om two and three Werent 
specimen sources, respectively, and hence they were 
counted only once in the analysis of the biochemical 
characteristics (Table 1) and in the fiequency distri- 
bution. C. koseri accounted for 19.8% (n=23) of all 
Citrobacter strains. Within the C. fieundii complex, 
C. fieundii was the most fi-equently identhed species 
(50.9%, n=59) followed by C. braakii (21.6%, n=25). 
From the 116 strains tested, only four strains of C. 
youngae, two strains of C. werkmanii and one strain of 
C. sedlakii were identlfied. No strains of C. amalonaticus, 
C.famzeri, Citrobacter species 9,  Citrobucter species 10 and 
Citrobacter species 11 were found. 
Specimen source 
F&y-seven of the 126 Citrobacter isolates (45.2%) were 
obtained fi-om the urinary tract. Twenty-nine (50.9%) 
urine specimens involved catheterized patients with 
serious debilitating conditions. From the 28 non- 
catheterized patients, only six isolates were associated 
with the presence of symptoms referable to the urinary 
tract. The remaining 22 isolates were obtained fiom 
patients without symptoms or patients with a recent 
history of catheterization. 
Forty-one of the 126 Citrobacter isolates (32.5%) 
were obtained fiom the respiratory tract. All isolates 
came fiom bronchus aspirates. Thirteen patients were 
intubated and one patient had a tracheostomy. Only 
seven patients (17.1%) showed signs consistent with 
pneumonia. Among the remaining 34 Citrobucter 
isolates, only four were not associated with an apparent 
predisposing factor such as intubation, tracheostomy, 
chronic pulmonary disease or some other debilitating 
disease. Sometimes a combination of these predlsposing 
factors was observed. 
Nineteen of the 126 Citrobacter isolates (15.1%) 
were obtained fi-om wound exudates originating tiom 
soft tissue or skin sites. Ten isolates of Citrobucter were 
associated with underlying gastrointestinal diseases 
and/or invasive procedures. The other specimens 
originated from a variety of superficial wounds, 
including foot ulcers, an injured leg stump, perianal 
abscesses, pus expressed fi-om an ear, a decubitus ulcer 
and paronychla. 
Nine of the 126 Citrobacter isolates (7.1%) were 
obtained fi-om blood cultures. In six patients the origin 
was probably the gastrointestinal tract, since positive 
blood cultures followed abdominal surgery. In all these 
cases Citrobacter was the only bacterium present in the 
blood culture. 
No clear relation was detected between any one of 
the Citrobacter species and a particular specimen source. 
Age, sex and medical department distribution of patients 
with Citroibacter isolates 
The age dlstribution of patients with Citrobacter isolates 
is shown in Figure 1. Of all Citrobucter specimens, 9% 
were obtained fiom patients before the age of 12 
months, while 77% of all isolates occurred at the age of 
> 50 years. 
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Table 1 Biochemical characteristics of Citrobarter species found in this study 
Test 
% of positive strains 
c. werkmanii C. koseri C. j e m d i i  C. braakii C. youngae 
(n=23) (n=59) (n=25) (n=4) (n=2) 
C. sedfakii 
(n=l) 
Indole 
H2S 
Citrate 
Malonate 
Acetate 
ADH 
ODC 
Acid produced &om: 
Adonitol 
D-Arabitol 
Dulcitol 
Melibiose 
a-Methyl-D-glucoside 
Raffinose 
Salicin 
Sucrose 
100 
0 
100 
100 
NT 
NT 
NT 
100 
100 
NT 
NT 
NT 
NT 
NT 
NT 
2 
71 
98 
3 
37 
92 
3 
0 
0 
14 
100 
100 
98 
2 (7) 
0 (7) 
0 
96 
92 
0 
36 
100 
92 
0 
0 
48 
96 (100) 
13 (54) 
12 (16) 
12 (16) 
0 
25 
100 
100 
0 
50 
100 
0 
0 
0 
100 
25 
0 
0 
25 
25 
0 
100 
100 
100 
100 
100 
0 
100 
0 
100 
100 
0 
100 
100 
0 
0 
100 
100 
0 
0 
0 
0 (100) 
~ ~ 
ADH= argmne dhydrolase, ODC= ormthme decarboxylase. Results were read after 2 days of incubanon 
The values in parentheses are the percentages of s t r m  which gave delayed-posnve reacnons. 
NT=not tested. 
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Figure 1 Age distribution of patients with Citrobacter isolates. 
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Citrobacter isolates were obtained h m  men more 
often than from women in reported specimen sources, 
except for the urinary tract specimens. No pattern of 
Citrobacter species by sex of patients was apparent. 
The various Citrobacter species appeared to be 
randomly dstributed over the medical departments 
in which the patients were hospitalized (geriatrics, 
pediatrics, surgery, intensive care unit and internal 
medicine). 
Additional organisms present in specimens 
Forty of the 57 urine specimens (70.2%) contained 
several other bacteria, mostly Enterobacteriaceae and 
non-fermenters. Catheterized patients were more 
likely to have polymicrobial bacteriuria (82.8% versus 
57.1%, p=0.04 by ch-square). Twenty-six of the 
41 respiratory tract specimens (63.4%) occurred as 
mixed cultures, mostly with yeasts, Enterobacteriaceae, 
staphylococci and non-fermenters. Fourteen of the 19 
wound specimens (73.7%) contained additional bacteria, 
particularly Enterobacteriaceae, non-fermenters and 
Gram-positive cocci. Four of the nine blood cultures 
(44.4%) had other pathogens in addition to Citrobacter. 
The additional organisms encountered were Staphylo- 
coccus aureus, Candida albicans, Escherichia coli and Entero- 
coccus species. 
Antimicrobial susceptibility 
Antimicrobial sensitivities of all Citrobacter st ra ins  were 
tested (Table 2). Species-related differences can be 
noted. AU strains of C. koseri were resistant to ampicillin, 
but sensitive to cefazolin, and 91% of the strains were 
sensitive to amoxiclavulanate. Within the C. jieundii 
complex, on the other hand, the majority of isolates 
were resistant to ampicillin (96.7%), amoxiclavulanate 
(98.9%) and cefazolin (96.7%). The sensitivities to 
antimicrobial agents of C. jieundii and C. braakii were 
comparable. Approximately 19% of the C. jieundii 
complex strains were multiply resistant to ampicillin, 
amoxiclavulanate, first-, second-, and third-generation 
cephalosporins and piperacillin. 
DISCUSSION 
A recent article from Brenner et al. introduced 11 
genomospecies within the genus Citrobacter based on 
DNA-relatedness studies. This study deals with 126 
Citrobacter isolates-collected during six successive 
months-from 116 patients staying at our university 
hospital. Identification of these Citrobacter strains was 
performed by means of conventional biochemical tests 
proposed by Brenner et al. [l]. The reported bio- 
chemical characteristics of the isolated Citrobacter 
species in this study (Table 1) correspond well with 
the results of Brenner et al. [l]. The most strilung 
flerences are the larger percentage of indole-negative 
C. jieundii and C. braakii and the larger percentage 
of HzS-positive C. braakii and C. youngae. Withn the 
C. jieundii complex, C. jieundii was the most common 
organism isolated, followed by C. braakii. This is in 
contrast to the results ofJanda et al. [12]; in their studies 
C. youngae came second instead of C. braakii. No strains 
of C. amalonaticus or C. fanneri were found in this study, 
suggesting that these species are less pathogenic for 
Table 2 Sensitivities to antimicrobial agents of Citrobacter species found in the study 
% of strains sensitive 
C. kosen' C. freundii C. braakii C. younpe C. werkmanii C. sedlakii 
Antimicrobial agent (n=23) (n=59) (n=25) (n=4) (n=2) (n=l )  
Ampicillin 
Amoxidavulanate 
Temocillin 
Piperacillin 
Pipera/Tazobactam 
Cefazolin 
Cehroxime 
C e f o b e  
Ceftazidime 
Cefepime 
Imipenem 
Co-trimoxazole 
Gentamicin 
Tobramycin 
AmikaCin 
Nitrofurantoin 
ofloxacin 
0 
91 
100 
87 
100 
100 
83 
100 
100 
100 
100 
100 
100 
100 
100 
87 
100 
2 
0 
98 
75 
78 
2 
66 
80 
80 
100 
98 
97 
100 
97 
97 
93 
93 
4 
4 
100 
84 
84 
8 
72 
88 
88 
100 
96 
100 
100 
100 
100 
100 
100 
0 
0 
100 
100 
100 
0 
100 
100 
100 
100 
100 
100 
100 
100 
100 
100 
100 
50 
0 
100 
100 
100 
0 
50 
100 
100 
100 
100 
100 
100 
100 
100 
100 
100 
0 
0 
100 
0 
0 
0 
0 
100 
100 
100 
100 
100 
100 
100 
100 
0 
100 
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humans. The urinary tract and the respiratory tract 
were predominant sites of isolation, accounting for 
45.2% and 32.5% of all isolates respectively. Citrobucter 
infections were seldom encountered between the age 
of 1 and 40. More than 77% of all Citrobacter isolates 
occurred after the age of 40. One more group that 
appears to be at a higher risk comprises young children 
(<12 months old). The majority of isolates came fi-om 
patients with previous surgery, who were admitted to 
an intensive care unit, or who had serious underlying 
diseases or malignancies. A striking experience in this 
study was the large amount of cultures containing other 
organisms in addition to Citrobacter. Two-thirds of all 
isolates occurred as part of a mixed infection. Our 
findings suggest that citrobacteria, like several other 
species of Enterobacteriaceae, are important oppor- 
tunistic microorganisms contributing to colonization 
or infection. The opportunistic character of citrobacteria 
is suggested by the age of &ected patients, the large 
proportion of mixed cultures, and the predisposing 
factors which were ofien present (e.g. intubation, 
mechanical ventilation, indwelling catheters, invasive 
procedures, serious compromising diseases). 
As mentioned in previous reports, we also found 
marked differences in the susceptibility patterns of 
C. koseri and the members of the C. jeundii  complex 
[2,9]. C. koseri strains were generally sensitive to 
amoxiclavulanate and cefazolin, but resistant to 
ampicillin. Members of the C.jeundii  complex, on the 
other hand, were generally resistant to ampican, 
amoxiclavulanate and cefazolin. There is sometimes a 
discordance between the activity of ampicillin and 
amoxiclavulanate for the members of the C. freundii 
complex. This is probably due to the intrinsic higher 
activity of ampicillin resulting from the production of 
an inducible chromosomally encoded type I cephalo- 
sporinase by these citrobacteria, which is not inhibited 
by clavulanic acid. A worrisome fact is the isolation of 
several strains of C. jeundi i  and C. braakii multiply 
resistant to the newer p-lactam antibiotics. 
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